Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Diagnosis of Acute Gouty Arthritis Obscured by Anchoring Bias

Sneha Patel, MD, Monica Mohile, MD, & Arundathi Jayatilleke, MD  |  Issue: April 2017  |  April 19, 2017

a. Yes, with a prevalence greater than that of the general population
b. No, with a prevalence less than that of the general population
c. No, with a prevalence equal to that of the general population

Gout can occur in patients with RA, but at a lower prevalence than that of the general population (2.4% vs. 5.2% over 25 years).4 Given the increased risk of joint destruction and clinical overlap, it is important to confirm the diagnosis of gout. Uncontrolled obesity, alcohol use and kidney disease increase the risk of developing gout.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

This patient was diagnosed with RA five years prior to admission on the basis of scleritis in the setting of a positive rheumatoid factor and cyclic citrullinated peptide. Because the patient was transitioning care, many past diagnoses remained fixed in his medical history. The patient had been diagnosed with gout many years earlier; however, he was never placed on a consistent uricosuric regimen and was actively treated only for RA.

After failing therapy with methotrexate, hydroxychloroquine, infliximab and tocilizumab, based on persistent symptoms and side effects, the patient was placed on abatacept as a long-term treatment regimen. His primary presentation on admission heightened concern for infection in the setting of active immune suppression.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Despite adjusting medications, in a five-year span, the patient had 15 clinical visits in which he described either mono- or polyarthritis. His persistent joint stiffness and limited range of motion in some joints despite treatment with abatacept led his clinicians to consider gout.

There are several documented instances in which this patient continued to demonstrate worsening arthralgia, despite medical therapy for RA. For example, he presented with synovitis of his right proximal interphalangeal joint and an elbow bursitis (CDAI score of 33). He was treated with prednisone for a presumed RA flare despite continued therapy on abatacept. Over the course of several months, his ongoing joint pain, which was refractory to abatacept and steroids, was considered to be due to his RA. A more diligent review of his persistent joint pain led to the diagnosis of gout.

In October 2015, the patient was to have left ankle surgery for erosive RA. In that time, the patient continued to complain of swelling in fingers and left wrist without significant improvement on his medications. Shortly after, the patient was admitted to the hospital as mentioned above.

Figures 3 & 4: X-rays of the Left Wrist

Figures 3 & 4: X-rays of the Left Wrist

Question 6

Is anchoring bias more prevalent in patients with many co-morbidities?

Page: 1 2 3 4 5 6 7 | Single Page
Share: 

Filed under:ConditionsGout and Crystalline Arthritis Tagged with:anchoring biasArthritiscase reportClinicalDiagnosisdiagnostic testingGoutinflammationjointoutcomepatient carepolyarthralgiaRArheumatologistrheumatologyseropositive rheumatoid arthritisTreatment

Related Articles

    Clinical Insights into Gout Management: Rheumatology Drugs at a Glance Pt. 4

    October 14, 2019

    Three clinical experts on gout offer their insights into common management errors, clinical pearls, new safety data from the FDA and the role of biologic therapies in the management of gout.

    Difficult Gout

    July 1, 2007

    “Grandpapa’s Torments” was the Rodnan Commemorative Gout Print featured at the 2005 ACR/ARHP Annual Scientific Meeting.

    Gout Research at a Glance: ‘My picks for the top research in gout presented at ACR Convergence 2021’

    November 10, 2021

    Dr. Lisa Stamp helps filter the noise to get to the key insights from the research abstracts on gout presented at ACR Convergence 2021.

    Lost and found

    Understanding the Role of Uric Acid in Gout

    September 6, 2022

    From the first substantial argument in the 19th century that uric acid played a role in gout, it took about 100 years for the medical community to accept its role in triggering acute inflammatory gout attacks. Two papers, both published in 1962, helped demonstrate the link between uric acid and acute gout attacks, quickly opening…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences